Eltrombopag 70771-1925
Product NDC
70771-1925- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 14, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA216281
Need to source Eltrombopag? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eltrombopag Olamine | 12.5 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Increased Megakaryocyte Maturation [PE]Increased Platelet Production [PE]
Packaging Options(1)
30 TABLET in 1 BOTTLE (70771-1925-3)